SCHEDULE: Ayrton Capital Reports 9.99% Stake in Bluejay Diagnostics

Ayrton Capital LLC, along with affiliated entities, has disclosed a beneficial ownership of 9.99% in Bluejay Diagnostics, Inc., primarily through shares and exercisable warrants.

Summary

• Ayrton Capital LLC, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, and Waqas Khatri have collectively reported beneficial ownership of 107,722 shares of Bluejay Diagnostics, Inc. common stock.
• This ownership represents 9.99% of the class of securities.
• The reported shares include 65,000 directly held shares and 42,722 shares issuable upon the exercise of warrants.
• The exercise of these warrants is subject to a 9.99% beneficial ownership blocker.
• The filing is made under Schedule 13G, indicating passive investment intent.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a significant ownership stake without immediate strategic implications.

Positives

• Significant ownership stake reported by Ayrton Capital and its affiliates, potentially indicating confidence in Bluejay Diagnostics.
• The reporting entities are investment professionals (IA and CO), suggesting a structured and informed investment approach.

Negatives

• The filing does not provide any operational or financial performance data for Bluejay Diagnostics.
• The beneficial ownership is capped at 9.99% due to a blocker provision on warrants, limiting immediate control or influence.

Risks

• The 9.99% beneficial ownership blocker on warrants means that any exercise beyond this threshold would require divestment or could trigger other provisions.
• The filing does not detail the specific terms or expiration of the warrants, which could impact future shareholding.

Future Outlook

The filing does not contain forward-looking statements or specific guidance regarding Bluejay Diagnostics' future performance. The outlook is limited to the reporting entities' investment position.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment. The 9.99% ownership threshold is a common strategy to avoid triggering stricter reporting requirements associated with controlling stakes.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by institutional investors may be viewed positively, but the passive nature of the filing limits immediate impact on control or strategy.
• Management: The reporting persons are investors and not involved in the day-to-day management of Bluejay Diagnostics.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The reporting persons will continue to monitor their investment in Bluejay Diagnostics.
• Further actions will depend on the company's performance and market conditions, within the constraints of the beneficial ownership blocker.

Key Dates

Keywords

Bluejay Diagnostics, Ayrton Capital, Alto Opportunity Master Fund, Waqas Khatri, Schedule 13G, Beneficial Ownership, Warrants, Investment Manager